Novalead Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.74 Cr
as on 18-12-2024
- Paid Up Capital ₹ 0.18 M
as on 18-12-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.34 Cr
as on 18-12-2024
- Revenue 513.86%
(FY 2023)
- Profit 353.23%
(FY 2023)
- Ebitda 53.09%
(FY 2023)
- Net Worth 17.90%
(FY 2023)
- Total Assets 18.52%
(FY 2023)
About Novalead Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.74 Cr and a paid-up capital of Rs 0.18 M.
The company has closed loans amounting to ₹3.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vandan Agrawal, Supreet Kiran, Atul Aslekar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73100PN2007PTC130929
- Company No.
130929
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2007
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Novalead Pharma?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Appaji  | Director | 17-Aug-2009 | Current |
| Girish Lakhe | Director | 17-Aug-2009 | Current |
| Atul Aslekar | Director | 31-Oct-2007 | Current |
| Vandan Agrawal | Nominee Director | 24-Nov-2022 | Current |
| Supreet Kiran | Director | 31-Oct-2007 | Current |
| Sankara Sankarasubramanian | Nominee Director | 24-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Novalead Pharma.
Novalead Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 513.86% increase. The company also saw a substantial improvement in profitability, with a 353.23% increase in profit. The company's net worth Soared by an impressive increase of 17.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novalead Pharma?
In 2023, Novalead Pharma had a promoter holding of 42.79% and a public holding of 57.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chellaram Shipping Private LimitedActive 25 years 5 monthsVandan Agrawal and Sankara Sankarasubramanian are mutual person
Chellaram FoundationActive 17 years 6 monthsVandan Agrawal and Sankara Sankarasubramanian are mutual person
Kishinchand Chellaram (India) Private LimitedActive 77 years 2 monthsVandan Agrawal and Sankara Sankarasubramanian are mutual person
- Lokumal Kishinchand Exports Private LimitedActive 37 years 11 months
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
- Boxmoor Shipping Private LimitedActive 20 years 8 months
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
- Edney Enterprises Private LimitedActive 6 years 11 months
Vandan Agrawal and Sankara Sankarasubramanian are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Biotechnology Industry Research Assistance Council Creation Date: 03 Jan 2011 | ₹3.34 Cr | Satisfied |
How Many Employees Work at Novalead Pharma?
Unlock and access historical data on people associated with Novalead Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novalead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalead Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
